For: | Chiou HE, Wang TE, Wang YY, Liu HW. Efficacy and safety of thalidomide in patients with hepatocellular carcinoma. World J Gastroenterol 2006; 12(43): 6955-6960 [PMID: 17109516 DOI: 10.3748/wjg.v12.i43.6955] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v12/i43/6955.htm |
Number | Citing Articles |
1 |
Hui-Ju Ch’ang. Optimal combination of antiangiogenic therapy for hepatocellular carcinoma. World Journal of Hepatology 2015; 7(16): 2029-2040 doi: 10.4254/wjh.v7.i16.2029
|
2 |
Ying Chun Shen, Chiun Hsu, Ann Lii Cheng. Molecular targeted therapy for advanced hepatocellular carcinoma. Targeted Oncology 2007; 2(4): 199 doi: 10.1007/s11523-007-0058-1
|
3 |
Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 2007; 16(6) doi: 10.1002/pds.1375
|
4 |
Masao Omata, Laurentius A. Lesmana, Ryosuke Tateishi, Pei-Jer Chen, Shi-Ming Lin, Haruhiko Yoshida, Masatoshi Kudo, Jeong Min Lee, Byung Ihn Choi, Ronnie T. P. Poon, Shuichiro Shiina, Ann Lii Cheng, Ji-Dong Jia, Shuntaro Obi, Kwang Hyub Han, Wasim Jafri, Pierce Chow, Seng Gee Lim, Yogesh K. Chawla, Unggul Budihusodo, Rino A. Gani, C. Rinaldi Lesmana, Terawan Agus Putranto, Yun Fan Liaw, Shiv Kumar Sarin. Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatology International 2010; 4(2): 439 doi: 10.1007/s12072-010-9165-7
|
5 |
Giuseppe Petralia, Nicola Fazio, Luke Bonello, Gabriele D'Andrea, Davide Radice, Massimo Bellomi. Perfusion Computed Tomography in Patients With Hepatocellular Carcinoma Treated With Thalidomide. Journal of Computer Assisted Tomography 2011; 35(2): 195 doi: 10.1097/RCT.0b013e31820ccf51
|
6 |
Soo-Fan Ang, Sze-Huey Tan, Han-Chong Toh, Donald Y.H. Poon, Simon Y.K. Ong, Kian-Fong Foo, Su-Pin Choo. Activity of Thalidomide and Capecitabine in Patients With Advanced Hepatocellular Carcinoma. American Journal of Clinical Oncology 2012; 35(3): 222 doi: 10.1097/COC.0b013e31820dbf56
|
7 |
Matthias Pinter, Martina Wichlas, Katharina Schmid, Christina Plank, Christian Müller, Friedrich Wrba, Markus Peck-Radosavljevic. Thalidomide in advanced hepatocellular carcinoma as antiangiogenic treatment approach: a phase I/II trial. European Journal of Gastroenterology & Hepatology 2008; 20(10): 1012 doi: 10.1097/MEG.0b013e3283036740
|
8 |
Antonio Garrido Serrano, Rafael León, Manuel Sayago, Jose Luis Márquez. Thalidomide Treatment in Cirrhotic Patients with Severe Anemia Secondary to Vascular Malformations. Digestive Diseases and Sciences 2012; 57(4): 1112 doi: 10.1007/s10620-011-1971-9
|
9 |
Jacqueline Whang-Peng, Ann-Lii Cheng, Chiun Hsu, Chien-Ming Chen. Clinical Development and Future Direction for the Treatment of Hepatocellular Carcinoma. Journal of Experimental & Clinical Medicine 2010; 2(3): 93 doi: 10.1016/S1878-3317(10)60016-2
|
10 |
Hui-Ju Ch’ang, Chiun Hsu, Chien-Hung Chen, Ya-Hui Chang, Jeffrey S. Chang, Li-Tzong Chen. Phase II Study of Concomitant Thalidomide During Radiotherapy for Hepatocellular Carcinoma. International Journal of Radiation Oncology*Biology*Physics 2012; 82(2): 817 doi: 10.1016/j.ijrobp.2010.10.067
|
11 |
Gary L. Davis, Jane Dempster, James D. Meler, Douglas W. Orr, Mark W. Walberg, Brian Brown, Brian D. Berger, John K. O'Connor, Robert M. Goldstein. Hepatocellular Carcinoma: Management of an Increasingly Common Problem. Baylor University Medical Center Proceedings 2008; 21(3): 266 doi: 10.1080/08998280.2008.11928410
|
12 |
De-Dong Cao, Hui-Lin Xu, Liang Liu, Yong-Fa Zheng, Si-Fa Gao, Xi-Ming Xu, Wei Ge. Thalidomide combined with transcatheter artierial chemoembolzation for primary hepatocellular carcinoma: a systematic review and meta-analysis. Oncotarget 2017; 8(27): 44976 doi: 10.18632/oncotarget.16689
|
13 |
Eric E. Prommer. Review Article: Palliative Oncology: Thalidomide. American Journal of Hospice and Palliative Medicine® 2010; 27(3): 198 doi: 10.1177/1049909109348981
|
14 |
Ying-Chun Shen, Chiun Hsu, Ann-Lii Cheng. Molecular targeted therapy for advanced hepatocellular carcinoma: current status and future perspectives. Journal of Gastroenterology 2010; 45(8): 794 doi: 10.1007/s00535-010-0270-0
|